TB-500


Synthetic peptide fragment of thymosin beta-4

A 43-residue acetylated synthetic peptide derived from the actin-sequestering protein thymosin beta-4, studied for tissue repair, cell migration, and angiogenic endpoints.

Abstract

TB-500 is the common research-grade designation for a synthetic acetylated peptide whose primary sequence is a fragment of human thymosin beta-4 (Tbeta4), a 43-residue actin-binding protein expressed at high concentration in platelets, leukocytes, and many other cells. The most frequently cited research-grade preparation is the full-length Tbeta4 sequence (43 amino acids; molecular weight approximately 4963 Da; CAS 77591-33-4) acetylated at the N-terminus to mimic the native post-translational modification. A small minority of vendor literature has used “TB-500” to refer to a shorter active fragment (LKKTETQ, residues 17 through 23 of Tbeta4), which is a different molecule with a different mass; investigators should confirm by mass spectrometry which sequence has been supplied. This monograph reviews the chemistry, mechanism, pharmacokinetics and analytical identity of the compound, with a curated reference list.

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human or animal consumption. All information is provided for research and educational purposes only.


Browse all monographs

Previous monograph
Next monograph